Tai Duong Thanh, Oanh Luong Thi, Phuong Pham Hoai, Sulieman Abdelmoneim, Abolaban Fouad A, Omer Hiba, Chow James C L
Department of Medical Physics, Faculty of Medicine, Nguyen Tat Thanh University, 298-300A Nguyen Tat Thanh Street, Ward 13, District 4, Ho Chi Minh City, Viet Nam.
Robarts Research Institute, London, Ontario, N6A 5K8, Canada.
Saudi J Biol Sci. 2022 Aug;29(8):103336. doi: 10.1016/j.sjbs.2022.103336. Epub 2022 Jun 2.
Dosimetric and radiobiological evaluations for the Jaws-only Intensity-modulated radiotherapy (JO-IMRT) technique for head and neck jaws-only intensity-modulated radiation therapy (JO-IMRT) and 3D conformal radiation therapy (3D-CRT). To compare the head-and-neck therapeutic approaches utilizing JO-IMRT and 3D-CRT techniques, different radiation dose indices were calculated, including: conformity index (CI), homogeneity index (HI), and radiobiological variables like Niemierko's equivalent uniform dose based tumor control probability (TCP) of planning target volume (PTV), normal tissue complication probability (NTCP) of organs at risk (OAR) (brainstem, spinal cord, and parotid grand).
Twenty-five nasopharynx patients were studied using the Prowess Panther Treatment Planning System (Prowess Inc). The results were compared with the dose distribution obtained using 3D-CRT.
Regarding tumor coverage and CI, JO-IMRT showed better results than 3D-CRT. The average doses received by the PTVs were quite similar: 72.1 ± 0.8 Gy by 3D-CRT and 72.5 ± 0.6 Gy by JO-IMRT plans (p > 0.05). The mean doses received by the parotid gland were 56.7 ± 0.7 Gy by 3D-CRT and 26.8 ± 0.3 Gy by JO-IMRT (p > 0.05). The HI and CI were 0.13 ± 0.01 and 0.14 ± 0.05 and (p > 0.05) by 3D-CRT and 0.83 ± 0.05 and 0.73 ± 0.10 by JO-IMRT (p < 0.05). The average TCP of PTV was 0.82 ± 0.08 by 3D-CRT and 0.92 ± 0.02 by JO-IMRT. Moreover, the NTCP of the parotid glands, brain stem, and spinal cord were lower using the JO-IMRT than 3D-CRT plans. In comparison to the 3D-CRT approach, the JO-IMRT technique was able to boost dose coverage to the PTV, improve the target's CI and HI, and spare the parotid glands. This suggests the power of the JO-IMRT over 3D-CRT in head-and-neck radiotherapy.
对头颈部仅下颌骨调强放射治疗(JO-IMRT)技术进行剂量学和放射生物学评估,并与三维适形放射治疗(3D-CRT)进行比较。为比较采用JO-IMRT和3D-CRT技术的头颈部治疗方法,计算了不同的辐射剂量指标,包括:适形指数(CI)、均匀性指数(HI)以及放射生物学变量,如基于尼米耶尔科等效均匀剂量的计划靶区(PTV)肿瘤控制概率(TCP)、危及器官(OAR)(脑干、脊髓和腮腺)的正常组织并发症概率(NTCP)。
使用Prowess Panther治疗计划系统(Prowess公司)对25例鼻咽癌患者进行研究。将结果与使用3D-CRT获得的剂量分布进行比较。
在肿瘤覆盖和CI方面,JO-IMRT显示出比3D-CRT更好的结果。PTV接受的平均剂量相当相似:3D-CRT为72.1±0.8 Gy,JO-IMRT计划为72.5±0.6 Gy(p>0.05)。腮腺接受的平均剂量3D-CRT为56.7±0.7 Gy,JO-IMRT为26.8±0.3 Gy(p>0.05)。3D-CRT的HI和CI分别为0.13±0.01和0.14±0.05(p>0.05),JO-IMRT为0.83±0.05和0.73±0.10(p<0.05)。PTV的平均TCP 3D-CRT为0.82±0.08,JO-IMRT为0.92±0.02。此外,JO-IMRT的腮腺、脑干和脊髓的NTCP低于3D-CRT计划。与3D-CRT方法相比,JO-IMRT技术能够提高对PTV的剂量覆盖,改善靶区的CI和HI,并保护腮腺。这表明JO-IMRT在头颈部放射治疗中优于3D-CRT。